HRGP (Innoventus Project)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHRGP (Innoventus Project)
Drug Alias Nameangiogenesis inhibitor (Innoventus)Histidine-Rich glycoprotein (Innoventus Project)HRGP
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoventus Project Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoventus Project Ab
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A